OpenLB
Open Library of Bioscience
Advanced Search
Infection and immunity
Nov, 2009;77 (11): 4690-5.

Susceptibility to infectious diseases based on antimicrobial peptide production.

Bruno Rivas-Santiago, Carmen J Serrano, J Antonio Enciso-Moreno
Author Information
  1. Bruno Rivas-Santiago: Unidad de Investigación Médica-Zacatecas, IMSS, Interior de la Alameda #45, Zacatecas, Zacatecas, Mexico.
PMID: 19703980 DOI: 10.1128/IAI.01515-08

Abstract

In the last few years, the great impact of antimicrobial peptides on infectious disease susceptibility and natural resistance has been reported. In some cases, susceptibility to diseases is related to antimicrobial peptide polymorphisms and gene copy numbers, but for the vast majority of infectious diseases, these phenomena need to be elucidated. This review is focused on the current knowledge about susceptibility and resistance conferred by genetic variations in antimicrobial peptide expression in infectious diseases.

References

  1. Invest Clin. 2008 Sep;49(3):411-41 [PMID: 18846780]
  2. AIDS. 2006 Aug 1;20(12):1673-5 [PMID: 16868452]
  3. J Clin Invest. 1998 Apr 15;101(8):1633-42 [PMID: 9541493]
  4. N Engl J Med. 2002 Oct 10;347(15):1199-200 [PMID: 12374882]
  5. Salud Publica Mex. 2006 Jan-Feb;48(1):62-71 [PMID: 16555536]
  6. Curr Opin Immunol. 2005 Aug;17(4):359-65 [PMID: 15955682]
  7. Nat Immunol. 2001 Dec;2(12):1133-7 [PMID: 11694882]
  8. Curr Opin Hematol. 2008 Jan;15(1):22-9 [PMID: 18043242]
  9. J Immunol. 2000 Dec 15;165(12):7102-8 [PMID: 11120840]
  10. Lancet. 2002 Oct 12;360(9340):1116-7 [PMID: 12387955]
  11. Am J Hum Genet. 2006 Sep;79(3):439-48 [PMID: 16909382]
  12. Nature. 2007 Oct 4;449(7162):564-9 [PMID: 17873860]
  13. PLoS One. 2009;4(2):e4496 [PMID: 19221600]
  14. BMC Infect Dis. 2002 Sep 18;2:20 [PMID: 12238953]
  15. J Clin Microbiol. 2003 Jan;41(1):90-6 [PMID: 12517831]
  16. Gene Ther. 2005 Oct;12(20):1494-502 [PMID: 15973442]
  17. Cell Mol Life Sci. 2003 Apr;60(4):711-20 [PMID: 12785718]
  18. J Immunol. 2003 Sep 15;171(6):3262-9 [PMID: 12960356]
  19. Nature. 2003 Apr 3;422(6931):522-6 [PMID: 12660734]
  20. J Infect Dis. 2006 May 15;193(10):1464-70 [PMID: 16619196]
  21. Scand J Infect Dis. 2001;33(7):483-7 [PMID: 11515755]
  22. Curr Opin Hematol. 2007 Jan;14(1):16-21 [PMID: 17133095]
  23. Curr Opin Immunol. 2002 Feb;14(1):96-102 [PMID: 11790538]
  24. Infect Immun. 2003 Mar;71(3):1109-15 [PMID: 12595421]
  25. Cell Microbiol. 2009 Feb;11(2):208-16 [PMID: 19068098]
  26. Int Arch Allergy Immunol. 2007;142(3):211-8 [PMID: 17108702]
  27. Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9178-83 [PMID: 16740661]
  28. J Immunol. 2006 Aug 1;177(3):1864-71 [PMID: 16849498]
  29. Immunity. 2006 Mar;24(3):341-8 [PMID: 16546102]
  30. FASEB J. 2004 Dec;18(15):1931-3 [PMID: 15456737]
  31. Infect Immun. 2004 May;72(5):2772-9 [PMID: 15102787]
  32. Nat Med. 2007 Aug;13(8):975-80 [PMID: 17676051]
  33. J Allergy Clin Immunol. 2006 Apr;117(4):836-41 [PMID: 16630942]
  34. J Exp Med. 2008 May 12;205(5):1121-32 [PMID: 18426984]
  35. J Clin Invest. 1998 Sep 1;102(5):874-80 [PMID: 9727055]
  36. Infect Immun. 2005 Aug;73(8):4505-11 [PMID: 16040961]
  37. Antimicrob Agents Chemother. 2005 Jul;49(7):2921-7 [PMID: 15980369]
  38. Pediatr Res. 2005 Jan;57(1):10-5 [PMID: 15531744]
  39. J Leukoc Biol. 2005 Apr;77(4):476-86 [PMID: 15629886]
  40. Infect Immun. 2007 Nov;75(11):5210-22 [PMID: 17664265]
  41. Lancet. 2002 Oct 12;360(9340):1144-9 [PMID: 12387964]
  42. J Am Soc Nephrol. 2007 Nov;18(11):2810-6 [PMID: 17942949]
  43. Inflamm Bowel Dis. 2003 Jul;9(4):215-23 [PMID: 12902844]
  44. Biochem Biophys Res Commun. 2002 Feb 15;291(1):17-22 [PMID: 11829455]
  45. Genes Immun. 2006 Jan;7(1):59-64 [PMID: 16435024]
  46. Nat Genet. 2008 Jan;40(1):23-5 [PMID: 18059266]
  47. J Immunol. 2007 Aug 15;179(4):2060-3 [PMID: 17675463]
  48. J Am Soc Nephrol. 2006 Dec;17(12):3267-3272 [PMID: 37001006]
  49. Scand J Immunol. 2008 May;67(5):448-52 [PMID: 18363594]
  50. Curr HIV Res. 2007 Jul;5(4):410-5 [PMID: 17627504]
  51. J Immunol. 2005 Jun 15;174(12):8003-10 [PMID: 15944307]
  52. Curr Pharm Des. 2007;13(2):163-72 [PMID: 17269925]
  53. J Acquir Immune Defic Syndr. 2009 Mar 1;50(3):331-3 [PMID: 19194307]
  54. J Infect Dis. 2006 Sep 1;194(5):697-701 [PMID: 16897670]
  55. J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):455-63 [PMID: 15021310]
  56. Nat Med. 2001 Feb;7(2):180-5 [PMID: 11175848]
  57. Curr Pharm Des. 2007;13(30):3084-95 [PMID: 17979751]
  58. J Mol Med (Berl). 2002 Sep;80(9):549-61 [PMID: 12226737]
  59. Nat Rev Microbiol. 2005 Mar;3(3):238-50 [PMID: 15703760]
  60. AIDS. 2004 Jul 23;18(11):1598-600 [PMID: 15238780]
  61. Infect Immun. 2002 Jun;70(6):3053-60 [PMID: 12010997]
  62. Curr Pharm Des. 2007;13(30):3065-72 [PMID: 17979749]
  63. Burns. 2000 Dec;26(8):724-6 [PMID: 11024605]
  64. N Engl J Med. 2002 Oct 10;347(15):1151-60 [PMID: 12374875]
  65. Cell. 1997 Feb 21;88(4):553-60 [PMID: 9038346]
  66. J Matern Fetal Neonatal Med. 2006 Jan;19(1):13-6 [PMID: 16572527]
  67. Science. 2006 Mar 24;311(5768):1770-3 [PMID: 16497887]
  68. J Clin Invest. 1988 Aug;82(2):552-6 [PMID: 2841356]
  69. Nature. 2002 Jan 24;415(6870):389-95 [PMID: 11807545]
  70. Nature. 2001 Nov 22;414(6862):454-7 [PMID: 11719807]
  71. Genomics. 1992 Dec;14(4):869-74 [PMID: 1282491]
  72. Curr Mol Med. 2002 Aug;2(5):469-77 [PMID: 12125812]
  73. Curr Opin Gastroenterol. 2007 Jan;23(1):32-8 [PMID: 17133082]
  74. Infect Immun. 2008 Mar;76(3):935-41 [PMID: 18160480]
  75. Expert Rev Anti Infect Ther. 2007 Dec;5(6):1049-57 [PMID: 18039087]
  76. J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):138-42 [PMID: 15905728]
  77. J Immunol. 1999 Dec 15;163(12):6718-24 [PMID: 10586069]
  78. J Immunol. 2003 Mar 15;170(6):3154-61 [PMID: 12626573]
  79. BMC Oral Health. 2006 Jun 15;6 Suppl 1:S13 [PMID: 16934114]
  80. Clin Exp Immunol. 2004 Aug;137(2):379-85 [PMID: 15270856]

MeSH Term

Animals
Antimicrobial Cationic Peptides
Communicable Diseases
Genetic Predisposition to Disease
Humans

Chemicals

Antimicrobial Cationic Peptides
Journal Article Review
Article has an altmetric score of 3

Word Cloud

Created with Highcharts 10.0.0antimicrobialinfectiousdiseasessusceptibilitypeptideresistancelastyearsgreatimpactpeptidesdiseasenaturalreportedcasesrelatedpolymorphismsgenecopynumbersvastmajorityphenomenaneedelucidatedreviewfocusedcurrentknowledgeconferredgeneticvariationsexpressionSusceptibilitybasedproduction

Similar Articles

Cited By